KAPA · Kairos Pharma, Ltd.
AI read · Bad for KAPA
The AI's read
With no sales coming in, Kairos had no revenue to cover its costs. Its operating loss grew, and the loss per share also grew from a year earlier. Together, those figures point to worsening business results.